Atlanta Braves Holdings, Inc. - Series A

As of September 30, 2026, Atlanta Braves Holdings, Inc. - Series C carries a market capitalization of 3.76B, placing it among publicly traded companies globally. Its enterprise value stands at 4.56B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Atlanta Braves Holdings, Inc. - Series C's next confirmed earnings release is scheduled for March 3, 2027.

As of September 30, 2026, Atlanta Braves Holdings, Inc. - Series C has 71.00M shares outstanding.

These figures are as of September 30, 2026. The price-to-sales ratio is 4.90, and the price-to-book ratio stands at 6.98.

These figures are as of September 30, 2026. The EV/Sales ratio of 5.98 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 4.56B versus a market cap of 3.76B, with the gap driven by net debt and cash on the balance sheet.

As of September 30, 2026, Atlanta Braves Holdings, Inc. - Series C maintains a current ratio of 0.52, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 165.29, indicating elevated leverage, while an interest coverage ratio of -0.37 demonstrates limited ability to service its debt obligations.

Over the twelve months ended September 30, 2026, Atlanta Braves Holdings, Inc. - Series C posted a negative return on equity (ROE) of -15.35, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -4.95, reflecting losses generated across the asset base. The company generates approximately 473,949.07 in revenue per employee across its workforce of 1,610.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended September 30, 2026, Atlanta Braves Holdings, Inc. - Series C recorded an income tax benefit of -17.24M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -101.43M and -84.36M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on November 6, 2026, Atlanta Braves Holdings, Inc. - Series C's stock has gained approximately 30.07% over the past 52 weeks. The 50-day moving average sits at 51.02, while the 200-day moving average is 48.42.

Over the twelve months ended September 30, 2026, Atlanta Braves Holdings, Inc. - Series C generated 763.06M in revenue and converted that into -84.36M in net income, yielding earnings per share of -1.19. EBITDA reached -17.70M, while operating income came in at -70.79M.

As of September 30, 2026, Atlanta Braves Holdings, Inc. - Series C holds 121.53M in cash and equivalents against 911.04M in total debt, resulting in a net debt position of 691.81M. Total book value stands at 538.83M, with working capital of -251.28M providing operational flexibility.

Atlanta Braves Holdings, Inc. - Series C produced -39.07M in operating cash flow over the twelve months ended September 30, 2026.

Over the twelve months ended September 30, 2026, Atlanta Braves Holdings, Inc. - Series C posted a gross margin of 21.64, reflecting its pricing power and cost economics. The operating margin of -9.28 and net profit margin of -11.06 provide insight into operational efficiency.

These figures cover the twelve months ended September 30, 2026. Free cash flow yield is negative at -1.04: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -2.59, meaning Atlanta Braves Holdings, Inc. - Series C raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of September 30, 2026, Atlanta Braves Holdings, Inc. - Series C has an Altman Z-Score of 1.43, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.